ArticleThe Journal of pharmacology and experimental therapeutics2017

Heterogeneous Binding and Central Nervous System Distribution of the Multitargeted Kinase Inhibitor Ponatinib Restrict Orthotopic Efficacy in a Patient-Derived Xenograft Model of Glioblastoma.

Janice K Laramy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.